Drug Type Small molecule drug |
Synonyms Amiloride/spironolactone, Spironolactone/Amiloride, Spironolactone/Amiloride-Hydrochloride + [1] |
Target |
Action inhibitors, antagonists |
Mechanism ENaCα inhibitors(sodium channel epithelial 1 subunit alpha inhibitors), MR antagonists(Mineralocorticoid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32O4S |
InChIKeyLXMSZDCAJNLERA-ZHYRCANASA-N |
CAS Registry52-01-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 2 | United States | - | - |
| Hypertension | Phase 2 | - | - | |
| Hypertension | Phase 2 | - | - |





